Cardiac magnetic resonance (CMR) it is a technique without radiation, which is considered the gold-standard for the evaluation of cardiac anatomy, function and even tissue composition. The RESILIENCE trial will use CMR as the main outcome measure methodology, and patients enrolled in the trial will undergo 3 scans across the duration of the study.
Multinational, prospective, proof of concept phase II, double-blinded, sham-controlled, randomized clinical trial (RCT) to evaluate the efficacy and safety of Remote Ischaemic Conditioning (RIC) in Lymphoma patients receiving anthracyclines. Patients scheduled to undergo ≥5 chemotherapy cycles will be eligible.
We are happy to share that our RESILIENCE project keeps on growing! Jacques Monod Hospital, part of the Le Havre Hospital Group and a reference hospital in the Seine Estuary Territory in France with a comprehensive range of care, joined RESILIENCE in November. At our meeting we talked about the project with Christophe Fruit, coordinator […]
